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ABSTRACT
Mission of biotechnology industries in terms of public health have been to improve and save human lives. In other words, biotechnology has been used 
to benefit the environment with new crops that reduce pesticide level and industrial enzymes that penetrate chemical waste and energy consumption 
during manufacturing. Now, biotechnological companies are able to develop products for national and homeland defense, i.e., vaccines, therapeutics, 
diagnostics, and rapid response systems including decontamination enzymes directing to attain the counterbalance of biological warfare agents. The 
most significant applications of modern biotechnology with respect to public health related to food production, epidemiological studies involving 
various infectious diseases, changes in climate and food security including malnutrition that introduced present day opportunities and challenges for 
human health and development.
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INTRODUCTION
Biotechnology has played a key role in improving public health and 
showed its immense prospective related to genomics, proteomics, 
virology, immunology, and other advances in the area of biotechnology 
to improve public health and reduce global health disparities [1,2]. 
Previously, benefits of plant or synthetically derived drugs are still not 
be able to reached millions of people in developing and non-developing 
countries [3]. It is crucial to recognize that biotechnology can be used 
very effectively in collaboration with public health practices all over 
the world and can enhance their efficacy [4]. To improve global health 
needs related to public health requires rapid and efficient diagnostic 
tools, efficient delivery methods related to drugs and vaccine antigens 
containing adjuvants, novel approaches for therapeutics agents 
(e.g., protein), and low-cost restoration of water, soil, and other natural 
resources [4,5]. In the present study, the present review discussed 
about these new emerging techniques for biotechnologies in terms of 
public health and explored how they can be used or supported the goals 
of developing and non-developing countries in terms of health and its 
immunity (Fig. 1).
Genetically modified organisms and malnutrition
Genetically modified organisms may affect human health indirectly 
through detrimental consequences on the environment or through 
adverse impacts on social, economic, and ethical factors. These 
consequences need to be assessed in relation to its benefits and risks that 
may arise from foods that have not been genetically reorganized [6,7], 
e.g., new conventionally bred varieties of a crop plant may also have 
impacts, i.e., both positive and negative in terms of human health and 
environment (Fig. 2).
Recombinant gene technology that enables plants, animals, and micro-
organisms to be genetically altered or modified with novel traits and 
recognized that techniques, i.e., cloning, tissue culture, and marker-
assisted breeding that are included in modern biotechnologies in 
addition to genetic modification [8,9]. The incorporation or addition 
of novel traits potentially offers enhanced agricultural productivity 
or upgrade its quality along with nutritional value and processing 
characteristics that can contribute directly to enhancing human health 
including its growth and development.
From public health perspective, it may also show indirect benefits, 
i.e., declining in agricultural chemical usage, crop sustainability, and 
food security, etc. Use of these novel traits in genetically modified 
organisms may also show some risks in terms of human health and 
development [10,11]. Most of the genes and its traits are reported and 
tried to use in agricultural genetically modified organisms, but few of 
them are novel and have no history of safe food use [11,12]. Several 
countries have introduced mandatory guidelines or legislation for 
premarket risk assessment of the genetically modified food. At the 
international level, agreements (contract) and standards are available 
to address these concerns in reducing the burden of malnutrition.
Malnutrition is a complex and multidimensional health problem in 
the field of biotechnology. In this regard, the world population was 
continuously increasing, which means that the portion or share of 
hungry people has drop down over the last four decades [13]. Normally, 
one in seven people still suffers from lack of food so that fighting hunger 
continues to be a challenge for humanity. Increasingly, these two forms of 
malnutrition, i.e., underweight and overweight, both of them are occurring 
at the same time within similar societies or even within the identical 
households [14,15]. As per the WHO 2011 reports, it estimates worldwide 
2 billion people are commonly anemic mainly due to iron deficiency, 
zinc deficiency [16], selenium deficiency [17], and vitamin A deficient 
along with a substantial proportion of pregnant women in at-risk areas 
equally being suspected of suffering from vitamin A deficiency [17,18]. In 
addition, low intake of calcium, vitamins (B and D), and folate can also be 
common [18]. Adding these figures related to deficiency of mineral ions 
including vitamins gives a total of at least 7 billion cases of people bearing 
from one form of malnutrition or another; out of these, 5 billion cases 
included under micronutrient deficiency [14-18]. Not all of the entire 
human population is affected by malnutrition; many individuals must 
suffer from multiple nutrition problems.
One question always kept in our mind that how biotechnology 
should improve or contribute in the field of hunger or malnutrition, 
e.g., around 2,50,000-5,00,000 vitamin A-deficient children (as per 
WHO reports) become blind every year as per the WHO reports, half of 
them dying within 12 months of losing their sight. Golden rice (reported 
by researchers in Germany and Switzerland) contains three new 
genes, i.e., daffodil (two) and bacterium (one) that help it to produce 
provitamin A [19], and this golden rice is available as an option for mass 
distribution (waiving of patent rights by biotechnology companies). It 
is just a single example among the hundreds of biotechnology-related 
products that are totally contributed to public health or society.
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Epidemiological studies
Disease surveillance systems provide the data that are needed for 
determining the public health status of populations [20]. Each disease 
surveillance system has some advantages and disadvantages while 
some disease surveillance systems measure incidence (occurrence of 
new cases over a period, and others measure prevalence (number of 
existing cases at one point in time).
Epidemiologists have intense interest in the differences between 
incidence and prevalence. Number of epidemiological studies that 
Fig. 1: Applications of biotechnology
Fig. 2: Genetically modified organisms
Fig. 3: Epidemiological diseases
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are conducted to determine which agent, host, or environmental 
factors are associated with the occurrence of a disease [20], e.g., ticks 
(ectoparasitic arthropods). The impact of ticks on human economy 
merits special consideration as they widely affect the health of man 
and his domestic wealth directly as well as indirectly. There are more 
than 900 known tick species worldwide, and approximately 130 are 
prevalent in Asia. Over the past two decades, the incidence of tick-
borne diseases has augmented considerably and poses a major health 
problem. Medically important tick-borne diseases include Lyme disease, 
tick-borne encephalitis, granulocytic ehrlichiosis, and babesiosis, which 
are prevalent in Asia. The major determinants found to be correlated 
with tick disease are called risk factors [20,21]. Identification and 
recognition of risk determinants can lead to increased perception of the 
disease process and possibly ratification or validation of disease control 
measures long before more comprehensive news about the cause 
of the disease can be confirmed [20,21]. A recent study has revealed 
the enhancement of tick disease incident in Baramati, Maharashtra, 
thereby stressing on the acute need in our country to develop solutions 
for control and management of ticks (Fig. 3).
It is estimated the global costs of ticks and tick-borne diseases in cattle 
between US$ 13.9 and US$ 18.7 billion annually. In India, the cost of 
tick-borne diseases in animals has been estimated in the tune of US$ 
498.7 million (more than 2000 crores) per annum. Due to the lack of 
effective vaccines against the tick-borne diseases of man and animals 
force us to look into judicious control of tick vectors in an integrated 
format for the effective control of tick-borne diseases. Reduction in 
the transmission of the tick-borne diseases by vaccination against tick 
vectors is not well established [20,21].
In this regard, biotechnological methods have been standardized for 
isolation of proteins from the tick salivary glands and design a strategy 
for the identification (2-D or de novo sequencing) separation and 
purification of the proteins. In addition, immunological and virological 
testing of the anti-tick compound and use as a probable candidate for 
vaccine development.
Change in climate and food security
Several factors that are responsible for climate change, e.g., enhancement 
in temperature, disturbances in rainfall patterns, and the outbreak of 
pests and diseases severely affected agricultural productivity including 
food security [22]. In other words, due to severe changes in climate, 
e.g., temperature showed significantly enhancement in risk factors 
related to production and rural vulnerability, particularly in those 
regions or areas that already suffer from chronic soil and water resource 
scarcity or high exposure to climatic extremes, i.e., droughts and 
flooding [22,23]. The effects of climate change are normally observed 
in agriculture area that may totally depend not only on transforming 
climatic conditions but also on the agricultural area that has the ability 
to alter some changes using biotechnology related to increase in food 
production [23]. Significant proportions of the growing populations in 
developing and non-developing countries derive their livelihoods from 
agriculture and are, therefore, vulnerable to climate change effects.
The task of eliminating paramount poverty and hunger will 
prerequisite both regional and global research attempts and showed 
its concrete actions among which biotechnology assumption that 
played a crucial role. Advances in the field of biotechnology can lead to 
cutting-edge technologies in agriculture [23,24]. Therefore, the major 
challenge for biotechnological industries is to improve the livelihoods 
of resource-poor farmers and also engaged in effective education and 
communication with the general public so as to enhance assumption of 
biotechnological products in India.
Food biotech labeling
Special labeling required only to disclose a material change, i.e., allergens 
(infectious agent) that are present in the food; high levels of naturally 
occurring toxins and changes to nutrient composition or profile. The 
major benefits of food technology, i.e., protects against mold in corn 
and enzymes that produce low-lactose milk more efficiently [23,24]. In 
contrast, major products being developed, i.e., protect rice and sugar 
cane from insects, produce a potato with reduced acrylamide levels, 
and remove allergenic proteins (e.g., peanuts, milk, and soy) [25].
New age vaccines
Vaccines represent most potent weapons against various infectious 
diseases. Most of the infectious agents are transmitted through sexual 
intercourse and number of microbial agents that may lead to the 
formation of the tumor and causes cancer. Till now, there is no vaccine 
available for these infectious diseases and due to its non-availability 
that is included in the world’s greatest public health problem [26,27]. 
For example in Asia, more than 200 million people died in Southern 
China and Southeast Asia because of hepatitis B virus and acted as 
carriers to spread it to others and ultimately caused liver cancer. A lot 
of research work has been carried out to improve its antigenicity or 
immunogenicity of vaccine antigen [28,29] against infectious diseases, 
e.g., flu and cholera using various medicinal plants or purified protein. 
In this regard, public health experts hope that worldwide diseases 
such as malaria and hepatitis B may be conquered because of vaccines 
that reduce its illness and causes death. In an effort to design and 
manufacturing, new type of vaccines that are envisioned for some 
infections that may be linked to cancer.
Nowadays, scientists focused on vaccine development and production 
for public health against infectious diseases and developed new 
techniques or strategy followed in the area of molecular biology 
especially recombinant DNA technology that was known as gene 
splicing [8,9] (take genes apart, add new fragments to the message 
and manufactured totally artificial genes). This technique has made it 
possible to grow in harmless bacteria containing large quantities of 
substances that can be used as the active ingredients of vaccines.
In view of this, edible vaccines hold great assurance as a cost-effective, 
easily stored and administered and sociocultural readily appropriate 
vaccine delivery system especially for poor-developing countries. In 
view of this, it involves selected desired genes that are introduced or 
inserted into the plants, and then, these altered plants to manufacture 
or produced the encoded proteins and may helpful in vaccine delivery 
systems for preventing infectious diseases. These edible vaccines 
showed some applications in prevention of autoimmune diseases, birth 
control, cancer therapy, etc. Nowadays, edible vaccines are currently 
being developed for a number of human and animal diseases [30].
CONCLUSION
Malnutrition, change in climate and food security, new age vaccines, 
food biotech, and epidemiological studies are recurring problem in 
most parts of the developing and non-developing countries. In view 
of this, many potential biotechnological companies that are accessible 
and available that can be applied to improve its farming productivity 
in places where there are food shortages and also helpful in enhancing 
the yield of nutrients through genetically modified food. In contrast, 
biotechnology may helpful in environment as well that can replace the 
petrochemicals in fibers and plastics using corn as the first renewable 
raw material. In addition, genetically engineered vaccines cannot 
cause the disease because the engineered bacteria cell or plant is 
just generate a protein that exists on the surface of a virus - not the 
whole virus. Overall, biotechnology is an important tool to fight against 
malnutrition, climate, and food security; epidemiological studies 
involving various infectious diseases.
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